Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Feb 1, 2016

5262_dirs_2016-02-01_2c9fd164-eb57-4641-8fec-8d5ce00bd7a8.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6532N

GlaxoSmithKline PLC

01 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

The Administrators of the GlaxoSmithKline US Deferred Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc (the 'Company') on 28 January 2016 that the under-mentioned Director and Person Discharging Managerial Responsibilities ('PDMR') acquired American Depositary Shares ('ADSs') at a price of $40.28 per ADS following the re-investment of the dividend paid to shareholders on 14 January 2016.

Director/PDMR ADSs
Dr M M Slaoui 288.211
Mr D E Troy 387.755

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLFLFBQLFEBBQ